{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:04:59Z","timestamp":1789419899099,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1215\/s1152851704000304","type":"journal-article","created":{"date-parts":[[2005,1,10]],"date-time":"2005-01-10T23:15:26Z","timestamp":1105398926000},"page":"41-48","source":"Crossref","is-referenced-by-count":60,"title":["Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell\nrescue, and radiotherapy for childhood high-grade glioma"],"prefix":"10.1093","volume":"7","author":[{"given":"Maura","family":"Massimino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Gandola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Luksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Solero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Giangaspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Podda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Bozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Pignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Collini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Cefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Terenziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Meazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Polastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Scaramuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ravagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Fossati-Bellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,1,1]]},"reference":[{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Ahmed, T., Feldman, E., Helson, L., Biguzzi, S., and Szalyga, A.\n(1990) Phase 1-2 trial of high dose thiotepa (HDT) with\nautologous bone marrow transplantation (ABMT) and localized radiotherapy (RT)\nfor patients (pts) with astrocytoma III-IV. Proc. Am. Assoc. Cancer\nRes.31,172\n (abstract).","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Al-Mefty, O., Al-Rodhan, N.R., Phillips, R.L., el-Senossi, M., and\nFox, J.L. (1987) Factors affecting survival of children with\nmalignant gliomas. Neurosurgery20,416\n-420.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Bahuau, M., Vidaud, D., Kujas, M., Palangie, A., Assouline, B.,\nChaignaud-Lebreton, M., Prieur, M., Vidaud, M., Harpey, J.P., Lafourcade, J.,\nand Caille, B. (1997) Familial aggregation of malignant\nmelanoma\/dysplastic naevi and tumours of the nervous system: An original\nsyndrome of tumour proneness. Ann. Genet.40, 78-91.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Balmaceda, C., Fetell, M.R., and Hesdorffer, C. (1997)\nThiotepa and etoposide treatment of recurrent malignant gliomas: Phase I\nstudy. Cancer Chemother. Pharmacol.40, 72-74.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Bertolone, S.J., Baum, E.S., Krivit, W., and Hammond, G.D.\n(1989) A phase II study of cisplatin therapy in recurrent\nchildhood brain tumors. A report from the Children's Cancer Study Group.\nJ. Neurooncol.7,5\n-11.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Bouffet, E., Mottolese, C., Jouvet, A., Philip, I., Frappaz, D.,\nCarrie, C., and Brunat-Mentigny, M. (1997) Etoposide and thiotepa\nfollowed by ABMT (autologous bone marrow transplantation) in children and\nyoung adults with high-grade gliomas. Eur. J. Cancer33, 91-95.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Busca, A., Miniero, R., Besenzon, L., Cordero di Montezemolo, L.,\nCenni, M., Fagioli, F., Sandri, A., Vassallo, E., Ricardi, U., and Madon, E.\n(1997) Etoposide-containing regimens with autologous bone marrow\ntrans-plantation in children with malignant brain tumors. Childs\nNerv. Syst.13,572\n-577.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Doz, F., Neuenschwander, S., Bouffet, E., Gentet, J.C., Schneider,\nP., Kalifa, C., Mechinaud, F., Chastagner, P., De Lumley, L., Sariban, E.,\nPlantaz, D., Mosseri, V., Bours, D., Alapetite, C., Zucker, J.M.\n(2002) Carbo-platin before and during radiation therapy for the\ntreatment of malignant brain stem tumours: A study by the\nSocie\u0301te\u0301 Franc\u0327aise d'Oncologie Pe\u0301diatrique.\nEur. J. Cancer38,815\n-819.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Duffner, P.K., Horowitz, M.E., Krischer, J.P., Friedman, H.S.,\nBurger, P.C., Cohen, M.E., Sanford, R.A., Mulhern, R.K., James, H.E., Freeman,\nC.R., Seidel, F.G., and Kun, L.E. (1993) Postoperative\nchemotherapy and delayed radiation in children less than three years of age\nwith malignant brain tumors. N. Engl. J. Med.328,1725\n-1731.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Finlay, J.L. (1996) The role of high-dose chemotherapy\nand stem cell rescue in the treatment of malignant brain tumors.\nBone Marrow Transplant.18(suppl 3), S1-S5.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Finlay, J.L., and Wisoff, J.H. (1999) The impact of\nextent of resection in the management of malignant gliomas of childhood.\nChilds Nerv. Syst.15,786\n-788.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Finlay, J.L., Boyett, J.M., Yates, A.J., Wisoff, J.H., Milstein,\nJ.M., Geyer, J.R., Bertolone, S.J., McGuire, P., Cherlow, J.M., Tefft, M.,\nTurski, P.A., Wara, W.M., Edwards, M., Sutton, L.N., Berger, M.S., Epstein,\nF., Ayers, G., Allen, J.C., and Packer, R.J. (1995) Randomized\nphase III trial in childhood high-grade astrocytoma comparing vincristine,\nlomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's\nCancer Group. J. Clin. Oncol.13,112\n-123.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Finlay, J.L., Goldman, S., Wong, M.C., Cairo, M., Garvin, J.,\nAugust, C., Cohen, B.H., Stanley, P., Zimmerman, R.A., Bostrom, B., Geyer,\nJ.R., Harris, R.E., Sanders, J., Yates, A.J., Boyett, J.M., and Packer, R.J.\n(1996) Pilot study of high-dose thiotepa and etoposide with\nautologous bone marrow rescue in children and young adults with recurrent CNS\ntumors. Children's Cancer Group. J. Clin. Oncol.14,2495\n-2503.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Finlay, J.L., Gardner, S., Moreno, S., Bayer, L., Dunkel, I.,\nJohnson, J., Pet-riccione, M., and Halpern, S. (1997) Sequential\nhigh-dose thiotepaa with autologous stem cell rescue (ASCR) in patients with\nprimary CNS tumors. J. Neurooncol.35 (suppl. 1), S16\n(abstract 46).","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Gnekow, A.K. (1995) Recommendations of the Brain Tumor\nSubcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee.\nInternational Society of Pediatric Oncology. Med. Pediatr.\nOncol.24,104\n-108.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Grovas, A.C., Boyett, J.M., Lindsley, K., Rosenblum, M., Yates,\nA.J., and Finlay, J.L. (1999) Regimen-related toxicity of\nmyeloablative chemo-therapy with BCNU, thiotepa, and etoposide followed by\nautologous stem cell rescue for children with newly diagnosed glioblastoma\nmulti-forme: Report from the Children's Cancer Group. Med. Pediatr.\nOncol.33,83\n-87.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Gururangan, S., Dunkel, I.J., Goldman, S., Garvin, J.H., Rosenblum,\nM., Boyett, J.M., Gardner, S., Merchant, T.E., Gollamudi, S., and Finlay, J.L.\n(1998) Myeloablative chemotherapy with autologous bone marrow\nrescue in young children with recurrent malignant brain tumors. J.\nClin. Oncol.16,2486\n-2493.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Hamilton, S.R., Liu, B., Parsons, R.E., Papadopoulos, N., Jen, J.,\nPowell, S.M., Krush, A.J., Berk, T., Cohen, Z., Tetu, B., Burger, P.C., Wood,\nP.A., Taqi, F., Booker, S.V., Petersen, G.M., Offerhaus, G.J.A., Tersmette,\nA.C., Giardiello, F.M., Vogelstein, B., and Kinzler, K.W. (1995)\nThe molecular basis of Turcot's syndrome. N. Engl. J.\nMed.332,839\n-847.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Heideman, R.L., Cole, D.E., Balis, F., Sato, J., Reaman, G.H.,\nPacker, R.J., Singher, L.J., Ettinger, L.J., Gillespie, A., Sam, J., and\nPoplack, D.G. (1989) Phase I and pharmacokinetic evaluation of\nthiotepa in the cere-brospinal fluid and plasma of pediatric patients:\nEvidence for dose-dependent plasma clearance of thiotepa. Cancer\nRes.49,736\n-741.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Heideman, R.L., Douglass, E.C., Krance, R.A., Fontanesi, J.,\nLangston, J.A., Sanford, R.A., Kovnar, E.H., Ochs, J., Kuttesch, J., Jenkins,\nJ.J., Fairclough, D.L., and Kun, L.E. (1993) High-dose\nchemotherapy and autologous bone marrow rescue followed by interstitial and\nexternal-beam radiotherapy in newly diagnosed pediatric malignant gliomas.\nJ. Clin. Oncol.11,1458\n-1465.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Hisada, M., Garber, J.E., Fung, C.Y., Fraumeni, J.F., Jr., and Li,\nF.P. (1998) Multiple primary cancers in families with Li-Fraumeni\nsyndrome. J. Natl. Cancer Inst.90,606\n-611.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Jakacki, R.I., Jamison, C., Heifetz, S.A., Caldemeyer, K., Hanna,\nM., and Sender, L. (1997) Feasibility of sequential high-dose\nchemotherapy and peripheral blood stem cell support for pediatric central\nnervous system malignancies. Med. Pediatr. Oncol.29,553\n-559.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Jakacki, R.I., Jamison, C., Mathews, V.P., Heilman, D.K., Dropcho,\nE., Cor-netta, K., Macdonald, D.R., and Williams, D.A. (1998)\nDose-intensifi-cation of procarbazine, CCNU (lomustine), vincristine (PCV)\nwith peripheral blood stem cell support in young patients with gliomas.\nMed. Pediatr. Oncol.31,483\n-490.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Kalifa, C., Hartmann, O., Demeocq, F., Vassal, G., Couanet, D.,\nTerrier-Lacombe, M.J., Valteau, D., Brugieres, L., and Lemerle, J.\n(1992) High-dose busulfan and thiotepa with autologous bone\nmarrow trans-plantation in childhood malignant brain tumors: A phase II study.\nBone Marrow Transplant.9, 227-233.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Kaplan, E.L., and Meier, P. (1958) Non parametric\nestimation from incom-plete observation. J. Am. Stat.\nAssoc.53,457\n-481.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Kedar, A., Maria, B.L., Graham-Pole, J., Ringdahl, D.M., Quisling,\nR.G., Mickle, J.P., Mendenhall, N.P., Marcus, R.B., Jr., and Gross, S.\n(1994) High-dose chemotherapy with marrow reinfusion and\nhyperfraction-ated irradiation for children with high-risk brain tumors.\nMed. Pediatr. Oncol.23,428\n-436.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Kreth, F.W., Berlis, A., Spiropoulou, V., Faist, M., Scheremet, R.,\nRossner, R., Volk, B., and Ostertag, C.B. (1999) The role of\ntumor resection in the treatment of glioblastoma multiforme in adults.\nCancer86,2117\n-2123.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Kuhl, J., Muller, H.L., Berthold, F., Kortmann, R.D., Deinlein, F.,\nMaass, E., Graf, N., Gnekow, A., Scheurlen, W., Gobel, U., Wolff, J.E.,\nBamberg, M., Kaatsch, P., Kleihues, P., Rating, D., Sorensen, N., and\nWiestler, O.D. (1998) Preradiation chemotherapy of children and\nyoung adults with malignant brain tumors: Results of the German pilot trial\nHIT'88\/'89. Klin. Padiatr.210,227\n-233.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Longee, D.C., Friedman, H.S., Albright, R.E., Jr., Burger, P.C.,\nOakes, W.J., Moore, J.O., and Schold, S.C., Jr. (1990) Treatment\nof patients with recurrent gliomas with cyclophosphamide and vincristine.\nJ. Neurosurg.72,583\n-588.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Marchese, M.J., and Chang, C.H. (1990) Malignant\nastrocytic gliomas in children. Cancer65,2771\n-2778.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Mason, W.P., Grovas, A., Halpern, S., Dunkel, I.J., Garvin, J.,\nHeller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D.,\nLindsley, K., Merchant, T.E., O'Malley, B., Bayer, L., Petriccione, M.M.,\nAllen, J., and Finlay, J.L. (1998) Intensive chemotherapy and\nbone marrow rescue for young children with newly diagnosed malignant brain\ntumors. J. Clin. Oncol.16,210\n-221.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Massimino, M., Gandola, L., Casanova, M., Cefalo, G., Ferrari, A.,\nLuksch, R., Riganti, G., and Lombardi, F. (2000a) Concomitant\nchemoradiotherapy for childhood poor-prognosis gliomas. Med.\nPediatr. Oncol.34,147\n-150.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Massimino, M., Gandola, L., Cefalo, G., Lasio, G., Riva, D.,\nFossati-Bellani, F., Gianni, M.C., Luksch, R., Tesoro-Tess, J.D., and\nLombardi, F. (2000b) Management of medulloblastoma and ependymoma\nin infants: A single-institution long-term retrospective report.\nChilds Nerv. Syst.16,15\n-20.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"McCowage, G.B., Friedman, H.S., Moghrabi, A., Kerby, T., Ferrell,\nL., Stewart, E., Duncan-Brown, M., Fuchs, H.E., Tien, R., McLendon, R.E.,\nMeier, L., Kurtzberg, J., Ashley, D., Colvin, O.M., and Longee, D.C.\n(1998) Activity of high-dose cyclophosphamide in the treatment of\nchildhood malignant gliomas. Med. Pediatr. Oncol.30, 75-80.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Packer, R.J., Yates, A., and Sposto, R. Re-evaluation of outcome in\nchildren with high-grade gliomas treated on a Children's Cancer Group Study\nCCG-943: A randomized study of radiation alone versus radiation plus\nadjuvant CCNU, prednisone and vincristine chemotherapy. 7th\nInternational Symposium: Pediatric Neuro-Oncology, May 15-18,1996\n, Washington, D.C. (abstract).","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Papadakis, V., Dunkel, I.J., Cramer, L.D., Kramer, E.,\nPapadopoulos, E., Goldman, S., Packer, R.J., Willoughby, M., Baker, D.,\nGarvin, J., Strandjord, S., Coccia, P., Kaplan, A.M., Klemperer, M., and\nFinlay, J.L. (2000) High d h-dose carmustine, thiotepa and\netoposide followed by autologous bone marrow rescue for the treatment of high\nrisk central nervous system tumors. Bone Marrow\nTransplant.26,153\n-160.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Papadopoulos, K.P., Garvin, J.H., Fetell, M., Vahdat, L.T.,\nGarrett, T.J., Savage, D.G., Balmaceda, C., Bruce, J., Sisti, M., Isaacson,\nS., DeLa Paz, R., Hawks, R., Bagiella, E., Antman, K.H., and Hesdorffer, C.S.\n(1998) High-dose thiotepa and etoposide-based regimens with\nautologous hematopoietic support for high-risk or recurrent CNS tumors in\nchildren and adults. Bone Marrow Transplant.22,661\n-667.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Pendergrass, T.W., Milstein, J.M., Geyer, J.R., Mulne, A.F.,\nKosnik, E.J., Morris, J.D., Heideman, R.L., Ruymann, F.B., Stuntz, J.T., and\nBleyer, W.A. (1987) Eight-drugs-in-one-day chemotherapy for brain\ntumors: Experience in 107 children and rationale for pre-radiation\nchemother-apy. J. Clin. Oncol.5,1221\n-1231.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Peto, R., and Peto, J. (1972) Asymptomatically\nefficient rank invariant test procedures. J. R. Stat. Soc. Ser.\nA135,185\n-207.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Pollack, I.F., Finkelstein, S.D., Woods, J., Burnham, J., Holmes,\nE.J., Hamilton, R.L., Yates, A.J., Boyett, J.M., Finlay, J.L., and Sposto, R.\nChildren's Cancer Group (2002) Expression of p53 and prognosis in\nchildren with malignant gliomas. N. Engl. J. Med.346,420\n-427.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Poppenborg, H., Munstermann, G., Knupfer, M.M., Hotfilder, M., and\nWolff, J.E. (1997) C6 cells cross-resistant to cisplatin and\nradiation. Anticancer Res.17,2073\n-2077.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Sposto, R., Ertel, I.J., Jenkin, R.D., Boesel, C.P., Venes, J.L.,\nOrtega, J.A., Evans, A.E., Wara, W., and Hammond, D. (1989) The\neffectiveness of chemotherapy for treatment of high grade astrocytoma in\nchildren: Results of a randomized trial. A report from the Children's Cancer\nStudy Group. J. Neurooncol.7, 165-177.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Terzis, A.J., Fiskerstrand, T., Refsum, H., Ueland, P.M., Arnold,\nH., and Bjerkvig, R. (1993) Proliferation, migration and invasion\nof human gli-oma cells exposed to antifolate drugs. Int. J.\nCancer54,112\n-118.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Wisoff, J.H., Boyett, J.M., Berger, M.S., Brant, C., Li, H., Yates,\nA.J., McGuire-Cullen, P., Turski, P.A., Sutton, L.N., Allen, J.C., Packer,\nR.J., and Finlay, J.L. (1998) Current neurosurgical management\nand the impact of the extent of resection in the treatment of malignant\ngliomas of childhood: A report of the Children's Cancer Group trial no.\nCCG-945. J. Neurosurg.89, 52-59.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Wolff, J.E., Gnekow, A.K., Kortmann, R.D., Pietsch, T., Urban, C.,\nGraf, N., and Kuhl, J. (2002a) Pre-radiation chemotherapy for\npediatric patients with high-grade glioma. Cancer94,264\n-271.","DOI":"10.3171\/jns.1998.89.1.0052"},{"key":"key\n\t\t\t\t20171013151117_","doi-asserted-by":"crossref","unstructured":"Wolff, J.E., Wagner, S., Sindichakis, M., Pietsch, T., Gnekow, A.,\nKortmann, R.D., Strater, R., and Kuehl, J. (2002b) Simultaneous\nradiochemotherapy in pediatric patients with high-grade glioma: A phase I\nstudy. Anticancer Res.22,3569\n-3572.","DOI":"10.3171\/jns.1998.89.1.0052"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/7\/1\/41\/13066197\/NO7-1_05Massimino_print.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T19:12:04Z","timestamp":1507921924000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/7\/1\/41\/1148288\/Sequential-chemotherapy-highdose-thiotepa"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1,1]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1215\/s1152851704000304","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2005,1,1]]}}}